Nitrofungyn NEO (chlorine) solution 25 ml. vial

Description

Nitrofungyn NEO composition
The main active ingredient contained in 1 ml: tridecanamine undecylenate – 4.4 mg.
Auxiliary components: triethylene glycol, ethanol 96%, purified water.

Release form
Sold as a solution for external use in 25 ml vials. Should be transparent and slightly yellowish, has a slight alcoholic odor.

Pharmacological properties
Nitrofungyn NEO belongs to the group of antifungal agents. The active ingredient of the drug is a derivative of undecylenic acid and is effective against Scopulariopsis and Candida, yeasts and facultative fungi.
The medicine exhibits both fungicidal and fungistatic effects. This is due to the fact that the active substance acts on the cell walls of pathogenic fungi.
The specified drug is active against fungi that cause dermatomycosis of the feet (tinea interdigitalis pedum), superficial epidermophytosis, trichophytosis, candidiasis and mixed infections of the skin and external auditory canal.
The most common source of infection is a sick person, as well as violation of hygiene rules (common shoes, towels, etc.). The state of the human immune system is also important in the manifestation of the disease.
Studies have shown that the drug is not absorbed through the skin. Thus, the drug does not have a negative effect on the internal organs of a person.

Indications
Nitrofungyn NEO is mainly used to treat fungal infections of the feet.
It can be used to combat nail fungal infections (onychomycosis) and hairy parts of the body.

Contraindications
The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or to one of the auxiliary components.

Children
The drug is not prescribed for children under 2 years of age.

Application during pregnancy and lactation
This drug is not recommended for pregnant women – only for strict indications determined by the attending physician.

Method of administration and dosage
Adults and children over 2 years of age apply the solution directly to the affected area of ​​the skin (preferably in the form of drops) or put a cotton swab moistened with the drug into the external auditory canal.
The procedure can be repeated at intervals of 8-12 hours (preferably in the morning and evening). The drug is used until the symptoms of the disease disappear.
Complete healing and prevention of relapses require the use of the drug for another several weeks, 2-3 times a week after the signs of infection disappear.
If long-term use leads to severe dryness and peeling of the skin, it is necessary to use ointments containing calcium pantothenate 2 more times a day.
If, within 7-14 days of using the drug, the symptomatology of the disease does not disappear, or, conversely, intensifies, you should consult with your doctor about its further use.

Overdose
To date, there is no information on cases of drug overdose.

Side effects
The drug is usually well tolerated when used in the recommended doses and in accordance with the recommended time interval.
Allergic reactions may occur at the site of application of the solution in case of individual intolerance. This manifests itself in the form of redness (flushing), swelling, rash, or itching.
After a short period of time, these phenomena disappear. However, if this does not occur, treatment should be discontinued.

Storage conditions and periods
Shelf life – up to 4 years from the production date indicated on the package. Storage periods should not be exceeded.
Storage temperature should not exceed 25 ° C. The drug must not be refrigerated or frozen.